ARDTArdent Health, Inc.
What is the market doing?
No clear lean: nothing decisive, though in an uptrend.
In an uptrend, above its rising 50- and 200-day averages. Price is +17% vs its 200-day average.
Moderately shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ARDT is trading
Ardent Health, Inc. is −12% over the past year while the S&P 500 is +18%: 30 points behind the market. Through the fall, its own insiders bought $186K more stock than they sold.
1-year return · S&P 500 +18%
- vs 200-day average
- +17%
vs 200-day average · a clear uptrend
- RSI (14)
- 64
RSI (14) · neutral
- Below its 52-week high
- 26%
Below its 52-week high
Details›
- Last close2026-10-09
- $11.32
- 1 monthS&P 500 +2.7%
- +3.9%
- 1 yearS&P 500 +18%
- −12%
- vs 50-day average$10.87
- +4.2%
- 52-week high
- $15.21
- 52-week low
- $7.83
- Annualised volatility
- 52%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $186K
| Year | Return |
|---|---|
| 2026 (year to date) | +28% |
| 2025 | −48% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 2 | 0 of 2 | −9.8% |
| Feb | 2 | 1 of 2 | +6.3% |
| Mar | 2 | 0 of 2 | −7.5% |
| Apr | 2 | 1 of 2 | +3.3% |
| May | 2 | 1 of 2 | +4.2% |
| Jun | 2 | 1 of 2 | −2.1% |
| Jul | 2 | 1 of 2 | +0.18% |
| Aug | 3 | 2 of 3 | +8.3% |
| Sep | 3 | 1 of 3 | −2.5% |
| Oct | 3 | 2 of 3 | +4.7% |
| Nov | 2 | 0 of 2 | −24% |
| Dec | 2 | 2 of 2 | +3.7% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.